Phase I first-in-human trial of SelG1 in healthy volunteers

Trial Profile

Phase I first-in-human trial of SelG1 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Nov 2016

At a glance

  • Drugs Crizanlizumab (Primary)
  • Indications Sickle cell anaemia
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Selexys Pharmaceuticals
  • Most Recent Events

    • 26 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top